Biomarin Pharmaceutical Q1 Adj $0.71 May Not Compare To $0.34 Estimate, Sales $648.83M Miss $651.79M Estimate

Author: Benzinga Newsdesk | April 24, 2024 04:05pm

Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.34 by 108.82 percent. This is a 18.33 percent increase over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $648.83 million which missed the analyst consensus estimate of $651.79 million by 0.45 percent. This is a 8.79 percent increase over sales of $596.41 million the same period last year.

Posted In: BMRN